“infectious-disease” Archives

in
Entry Author Date Location
GSK Pays CureVac $328M in mRNA Vaccines Pact—Excluding COVID-19 07/20/20 Europe
Bristol Myers Pays Dragonfly $55M to Bring NK Cells to Neuro Diseases 07/06/20 Boston
Affinivax Lands $120M to Take MAPS Tech Into New Vaccine Territory 04/23/20 Boston
Pfizer, BioNTech Say mRNA COVID-19 Vaccine Trials May Start This Month 04/09/20 National
Roche Pays $190M to Start RNA Drug Alliance With Arrakis Therapeutics 04/08/20 Boston
Bio Roundup: Pandemic Declared, Rubius Restarts, Kymera’s Cash & More 03/13/20 National
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14 01/30/20 San Francisco
Of Science and Sea Urchins: Researchers Plumb Oceans for Biological Insights 01/21/20 Boston
Bio Roundup: So Long Celgene, RNAi’s Arrival, Pharma in 2020 & More 11/22/19 National
Vir Bio’s IPO Brings In $143M for Tests of Hepatitis B Drug and More 10/11/19 San Francisco
Vir Bio Plans IPO to Fund Clinical Trials of Infectious Disease Drugs 09/03/19 San Francisco
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses 12/18/18 Texas
Brii Biosciences Debuts with a China Pharma Strategy Backed by $260M 05/24/18 Raleigh Durham
Diabetes, Infectious Diseases Early Focus of San Antonio Biomed Plan 12/13/17 Texas
Medicines Co. Sells Infectious Disease Drugs, Focusing on PCSK9 11/29/17 New York
Scangos Heats Up Xconomy’s What’s Hot in Bay Area Biotech Lineup 11/02/17 San Francisco
Arsanis Eyes IPO to Support Clinical Testing of Pneumonia Drug 10/23/17 Boston
Vir Biotech Vies for Global Approach to Tackling Infectious Disease 10/18/17 San Francisco
SRI’s Michigan Office Will Help Develop New VEE Vaccine 05/15/17 Detroit Ann Arbor
With Government Backing, Moderna Joins the Zika Vaccine Chase 09/07/16 Boston
Slowing the Global Spread of Climate-Sensitive Infectious Diseases 11/19/15 Seattle
Video Chatting May Be the Future of Medicine, Just Not Yet 06/22/15 Boston
Moderna Forms Latest Venture, Valera, to Fight Infections With mRNA 01/08/15 Boston
J&J, GSK, Tekmira, And Others Take Next Steps To Fight Ebola 10/22/14 Boston
Seres Makes Push for First Drug, and IPO, of Microbiome Era 07/16/14 Boston
Brazil: Ready for Future Growth in Health Care 07/09/14 Seattle
Lucigen Takes On Diagnostic Giants With On-the-Spot Pathogen Tests 01/30/14 Wisconsin
Sarepta Moves From Seattle to Boston for the Talent 09/07/12 Seattle
Sarepta Holds Its Breath as Feds Order Halt to Ebola Work 08/07/12 Seattle
Theraclone Passes First Clinical Test with Flu-Fighting Antibody 05/15/12 Seattle
Page 1 of 2 next page »